UC San Diego Leads Research that Earns Gordon Bell Special Prize
November 19, 2020
Computational Chemist Rommie Amaro, members of her lab win one of the most coveted awards in supercomputing for research related to COVID-19
Your search for “Drug discovery” returned 447 results
Newly Identified Target May Help with Drug Discovery for Chronic Inflammatory Diseases
July 25, 2018
In a study published online July 25 in the journal Nature, University of California San Diego School of Medicine researchers identified a signaling pathway that activates the NLRP3 inflammasome implicated in several severe chronic inflammatory disorders.
$2.5M Gift Targets Gaps in Circadian Biology and Medicine
May 23, 2023
A $2.5 million initiative supported by philanthropists Irwin and Joan Jacobs has created the Stuart and Barbara L. Brody Endowed Chair in Circadian Biology and Medicine, along with a supporting research fund, to target largely unexplored areas related to circadian biology and patient health.
Discovery of New Biomarker in Blood Could Lead to Early Test for Alzheimer’s Disease
March 31, 2020
UC San Diego researchers discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer’s. The work could lead to the development of a blood test to identify individuals who will develop the disease years before they show symptoms.
Nobel Laureate to be Honored at 19th Annual Luau and Longboard Invitational August 19
July 26, 2012
…way to image and possibly even deliver specially targeted drugs to cancer tumors.
UC San Diego Cancer Scientists Named to First Class of AACR Fellows
March 27, 2013
Five University of California, San Diego scientists and professors are among the first class of the Fellows of the American Association for Cancer Research Academy, created to recognize researchers whose scientific contributions have propelled significant innovation and progress against cancer. The entire class consists of 106 individuals, to celebrate the…
Underlying Molecular Networks Suggest New Targets to Combat Brain Cancer
July 25, 2016
Glioblastoma is a highly aggressive form of brain cancer with a survival rate generally less than 16 months. With no effective treatments available, a team including researchers from the San Diego Supercomputer Center (SDSC) at UC San Diego and John Wayne Cancer Institute at Providence Saint John’s Health Center sought…
UC San Diego Researchers Discover Key Mechanisms behind Synapse Degeneration in Alzheimer’s Brain
August 18, 2021
Neurobiologists have uncovered the mechanisms behind the maintenance and decline of key synapses implicated in Alzheimer’s disease. The findings suggest an alternative approach to addressing such brain disorders.
Mapping Mutation ‘Hotspots’ in Cancer Reveals New Drivers and Biomarkers
February 9, 2022
UC San Diego researchers have identified a previously unrecognized key player in cancer evolution: clusters of mutations occurring at certain regions of the genome. These mutation clusters contribute to the progression of about 10% of human cancers and can be used to predict patient survival.
Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation
June 8, 2021
Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.
